Multiple downstream cellular targets via secreted paracrine factors

Multiple downstream cellular targets via secreted paracrine factors is a descriptive term for a complex pharmacological mechanism rather than a single molecular entity. This process involves a primary cell or therapeutic agent releasing a diverse array of signaling molecules—such as cytokines, chemokines, and growth factors—into the extracellular space to influence neighboring cells (Gnecchi et al., 2016, Circ Res). This paracrine signaling allows for the simultaneous modulation of various biological pathways, including angiogenesis, immune regulation, and tissue repair (Vizoso et al., 2017, Int J Mol Sci). It is most commonly associated with regenerative medicine and cell-based therapies, such as mesenchymal stem cell (MSC) treatments, where the 'secretome' is responsible for the observed clinical efficacy (Teixeira et al., 2013, J Biomed Mater Res). In cancer therapy, a similar concept known as the 'bystander effect' occurs when a drug-modified cell releases metabolites that affect adjacent non-modified cells. Because this term encompasses a broad range of distinct molecular interactions across multiple cell types, it is classified as a mechanism of action or a physiological process rather than a discrete, druggable protein target.

Other names

Paracrine signaling mechanismSecretome-mediated signalingBystander effectIndirect cellular modulationParacrine effect

The therapeutic agent (typically a cell or gene therapy) induces the release of a diverse cocktail of bioactive molecules, known as the secretome, which then bind to various receptors on neighboring cells to elicit a multi-faceted biological response.